Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 72 | 2024 | 1897 | 9.110 |
Why?
|
Sleep Apnea Syndromes | 22 | 2024 | 982 | 6.020 |
Why?
|
Polysomnography | 56 | 2024 | 1868 | 4.870 |
Why?
|
Continuous Positive Airway Pressure | 23 | 2024 | 581 | 2.230 |
Why?
|
Snoring | 7 | 2024 | 211 | 2.030 |
Why?
|
Arousal | 16 | 2023 | 1174 | 1.920 |
Why?
|
Osteoporotic Fractures | 4 | 2023 | 417 | 1.680 |
Why?
|
Sound Spectrography | 4 | 2012 | 114 | 1.410 |
Why?
|
Sleep | 29 | 2024 | 4816 | 1.360 |
Why?
|
Respiration | 12 | 2022 | 1655 | 1.300 |
Why?
|
Pharynx | 10 | 2024 | 436 | 1.200 |
Why?
|
Cardiovascular Diseases | 11 | 2024 | 15645 | 1.190 |
Why?
|
Heart Rate | 9 | 2024 | 4209 | 1.170 |
Why?
|
Auscultation | 3 | 2012 | 38 | 1.100 |
Why?
|
Atherosclerosis | 7 | 2023 | 3418 | 1.050 |
Why?
|
Mandibular Advancement | 2 | 2022 | 64 | 0.950 |
Why?
|
Epiglottis | 4 | 2024 | 81 | 0.820 |
Why?
|
Disorders of Excessive Somnolence | 2 | 2024 | 279 | 0.810 |
Why?
|
Hypertension | 6 | 2024 | 8615 | 0.800 |
Why?
|
Sleep Stages | 3 | 2018 | 705 | 0.760 |
Why?
|
Blood Circulation | 1 | 2020 | 248 | 0.660 |
Why?
|
Palate | 3 | 2024 | 126 | 0.660 |
Why?
|
Sleep, REM | 6 | 2022 | 593 | 0.650 |
Why?
|
Mandelic Acids | 5 | 2022 | 46 | 0.620 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6573 | 0.570 |
Why?
|
Tongue | 7 | 2024 | 406 | 0.540 |
Why?
|
Respiratory Sounds | 4 | 2013 | 702 | 0.510 |
Why?
|
Automobile Driving | 1 | 2020 | 442 | 0.480 |
Why?
|
Tachycardia | 2 | 2014 | 598 | 0.450 |
Why?
|
Mouth Breathing | 2 | 2024 | 25 | 0.450 |
Why?
|
Pattern Recognition, Automated | 2 | 2010 | 987 | 0.440 |
Why?
|
Oxygen | 6 | 2024 | 4252 | 0.440 |
Why?
|
Posture | 3 | 2017 | 956 | 0.430 |
Why?
|
Adrenergic Uptake Inhibitors | 4 | 2021 | 186 | 0.390 |
Why?
|
Occlusal Splints | 2 | 2022 | 18 | 0.390 |
Why?
|
Male | 64 | 2024 | 364203 | 0.380 |
Why?
|
Middle Aged | 53 | 2024 | 223233 | 0.380 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2012 | 700 | 0.370 |
Why?
|
Risk Assessment | 3 | 2023 | 24299 | 0.370 |
Why?
|
Humans | 95 | 2024 | 767040 | 0.370 |
Why?
|
Acute Coronary Syndrome | 1 | 2023 | 2193 | 0.360 |
Why?
|
Severity of Illness Index | 6 | 2024 | 15925 | 0.360 |
Why?
|
Muscle Hypotonia | 2 | 2022 | 166 | 0.350 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2012 | 1458 | 0.340 |
Why?
|
Endoscopy | 6 | 2024 | 1854 | 0.320 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5886 | 0.300 |
Why?
|
Body Size | 1 | 2011 | 462 | 0.290 |
Why?
|
Pharyngeal Diseases | 2 | 2019 | 134 | 0.290 |
Why?
|
Female | 55 | 2024 | 396660 | 0.290 |
Why?
|
Wakefulness | 7 | 2023 | 1282 | 0.270 |
Why?
|
Aged | 28 | 2024 | 171319 | 0.270 |
Why?
|
Hypoglossal Nerve | 2 | 2024 | 110 | 0.260 |
Why?
|
Cross-Over Studies | 9 | 2024 | 2105 | 0.240 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2024 | 69 | 0.230 |
Why?
|
Cohort Studies | 8 | 2024 | 41718 | 0.220 |
Why?
|
Acetazolamide | 1 | 2024 | 98 | 0.220 |
Why?
|
Adult | 37 | 2024 | 223317 | 0.220 |
Why?
|
Electromyography | 5 | 2023 | 1398 | 0.210 |
Why?
|
Parasympatholytics | 2 | 2020 | 89 | 0.200 |
Why?
|
Electroencephalography | 8 | 2024 | 6282 | 0.200 |
Why?
|
Oropharynx | 2 | 2024 | 139 | 0.200 |
Why?
|
Prospective Studies | 8 | 2024 | 54886 | 0.190 |
Why?
|
Oximetry | 2 | 2023 | 462 | 0.180 |
Why?
|
Tonsillectomy | 1 | 2024 | 281 | 0.180 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 253 | 0.180 |
Why?
|
Facial Muscles | 1 | 2022 | 159 | 0.180 |
Why?
|
Muscarinic Antagonists | 1 | 2021 | 135 | 0.180 |
Why?
|
Blood Circulation Time | 1 | 2020 | 10 | 0.180 |
Why?
|
Prognosis | 1 | 2021 | 29963 | 0.170 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 373 | 0.170 |
Why?
|
Pressure | 3 | 2019 | 1172 | 0.170 |
Why?
|
Mouth | 1 | 2022 | 383 | 0.170 |
Why?
|
Reproducibility of Results | 6 | 2021 | 20169 | 0.160 |
Why?
|
Algorithms | 9 | 2021 | 14098 | 0.160 |
Why?
|
Exhalation | 2 | 2018 | 185 | 0.160 |
Why?
|
Airway Obstruction | 1 | 2024 | 672 | 0.160 |
Why?
|
Psychomotor Performance | 2 | 2024 | 1886 | 0.160 |
Why?
|
Regression Analysis | 3 | 2024 | 6331 | 0.150 |
Why?
|
Principal Component Analysis | 2 | 2012 | 950 | 0.150 |
Why?
|
Prolapse | 1 | 2018 | 63 | 0.150 |
Why?
|
Body Mass Index | 4 | 2024 | 13048 | 0.150 |
Why?
|
Electrooculography | 1 | 2018 | 112 | 0.150 |
Why?
|
Lung Compliance | 1 | 2018 | 207 | 0.150 |
Why?
|
Blood Pressure Determination | 1 | 2022 | 646 | 0.150 |
Why?
|
Palate, Soft | 1 | 2018 | 100 | 0.150 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2018 | 143 | 0.150 |
Why?
|
ROC Curve | 2 | 2018 | 3618 | 0.140 |
Why?
|
Trachea | 3 | 2013 | 1095 | 0.140 |
Why?
|
4-Aminopyridine | 1 | 2017 | 77 | 0.140 |
Why?
|
Nipecotic Acids | 1 | 2017 | 36 | 0.140 |
Why?
|
Potassium Channel Blockers | 1 | 2017 | 162 | 0.140 |
Why?
|
Basal Metabolism | 1 | 2017 | 163 | 0.130 |
Why?
|
Desipramine | 1 | 2016 | 183 | 0.130 |
Why?
|
Double-Blind Method | 8 | 2024 | 12451 | 0.130 |
Why?
|
Pharyngeal Muscles | 3 | 2023 | 81 | 0.130 |
Why?
|
Blood Pressure | 4 | 2024 | 8531 | 0.130 |
Why?
|
Manitoba | 1 | 2015 | 24 | 0.130 |
Why?
|
Morbidity | 1 | 2021 | 1754 | 0.130 |
Why?
|
Heart Failure | 1 | 2020 | 11877 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2023 | 839 | 0.120 |
Why?
|
Twins, Monozygotic | 1 | 2017 | 471 | 0.120 |
Why?
|
Tidal Volume | 1 | 2017 | 519 | 0.120 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2018 | 418 | 0.120 |
Why?
|
Treatment Outcome | 10 | 2024 | 65295 | 0.120 |
Why?
|
Respiratory System | 1 | 2018 | 563 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1255 | 0.120 |
Why?
|
Obesity | 4 | 2024 | 13085 | 0.120 |
Why?
|
Wavelet Analysis | 1 | 2014 | 56 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 940 | 0.110 |
Why?
|
Pulmonary Ventilation | 2 | 2016 | 374 | 0.110 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14672 | 0.110 |
Why?
|
Pregnancy Outcome | 1 | 2024 | 2972 | 0.110 |
Why?
|
Drug Combinations | 1 | 2019 | 2086 | 0.100 |
Why?
|
Hypnotics and Sedatives | 1 | 2021 | 1193 | 0.100 |
Why?
|
Heart | 2 | 2023 | 4429 | 0.100 |
Why?
|
Phenotype | 5 | 2022 | 16718 | 0.100 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2021 | 1107 | 0.100 |
Why?
|
Pilot Projects | 2 | 2022 | 8732 | 0.100 |
Why?
|
Aging | 1 | 2011 | 8729 | 0.100 |
Why?
|
Muscles | 1 | 2016 | 1576 | 0.100 |
Why?
|
Risk Factors | 7 | 2024 | 74886 | 0.090 |
Why?
|
United States | 6 | 2024 | 72971 | 0.090 |
Why?
|
Oxygen Consumption | 1 | 2017 | 1873 | 0.090 |
Why?
|
Anthropometry | 2 | 2016 | 1345 | 0.090 |
Why?
|
Fuzzy Logic | 1 | 2010 | 58 | 0.090 |
Why?
|
Acoustics | 1 | 2012 | 237 | 0.090 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2131 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12536 | 0.080 |
Why?
|
Young Adult | 7 | 2024 | 59980 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2024 | 12069 | 0.080 |
Why?
|
Logistic Models | 4 | 2024 | 13284 | 0.080 |
Why?
|
Diaphragm | 2 | 2022 | 357 | 0.070 |
Why?
|
Respiratory Rate | 2 | 2021 | 179 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26325 | 0.070 |
Why?
|
Drug Therapy, Combination | 3 | 2024 | 6310 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2012 | 6215 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2299 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2023 | 59548 | 0.060 |
Why?
|
Lung | 5 | 2023 | 10076 | 0.060 |
Why?
|
Electrocardiography | 1 | 2018 | 6409 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2350 | 0.060 |
Why?
|
Time Factors | 3 | 2021 | 40154 | 0.060 |
Why?
|
Photoplethysmography | 1 | 2024 | 66 | 0.060 |
Why?
|
Airway Resistance | 1 | 2024 | 407 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15424 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2010 | 2721 | 0.050 |
Why?
|
Sex Factors | 2 | 2021 | 10622 | 0.050 |
Why?
|
Nose | 2 | 2018 | 522 | 0.050 |
Why?
|
Sound | 1 | 2024 | 257 | 0.050 |
Why?
|
Linear Models | 2 | 2024 | 5875 | 0.050 |
Why?
|
Maximum Tolerated Dose | 1 | 2024 | 896 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 21526 | 0.050 |
Why?
|
Vasoconstriction | 1 | 2024 | 591 | 0.050 |
Why?
|
Parity | 1 | 2024 | 931 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 326 | 0.040 |
Why?
|
Patient Positioning | 1 | 2022 | 332 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2024 | 8535 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2127 | 0.040 |
Why?
|
Sex Characteristics | 2 | 2020 | 2647 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2022 | 965 | 0.040 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 1 | 2018 | 19 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12790 | 0.040 |
Why?
|
Electric Stimulation Therapy | 1 | 2024 | 635 | 0.040 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2024 | 529 | 0.040 |
Why?
|
Transcription Factors | 1 | 2018 | 12158 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2023 | 707 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 135 | 0.040 |
Why?
|
Fingers | 1 | 2020 | 508 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2024 | 22254 | 0.030 |
Why?
|
Reaction Time | 1 | 2023 | 2086 | 0.030 |
Why?
|
Actigraphy | 1 | 2020 | 527 | 0.030 |
Why?
|
Supine Position | 1 | 2016 | 208 | 0.030 |
Why?
|
Birth Weight | 1 | 2024 | 2122 | 0.030 |
Why?
|
Automation | 1 | 2018 | 587 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 944 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 516 | 0.030 |
Why?
|
Artificial Intelligence | 1 | 2010 | 2666 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1587 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1695 | 0.030 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 1263 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2017 | 996 | 0.030 |
Why?
|
Muscle Contraction | 1 | 2018 | 1208 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4627 | 0.030 |
Why?
|
ras Proteins | 1 | 2018 | 1054 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2850 | 0.030 |
Why?
|
Weight Loss | 1 | 2024 | 2716 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3851 | 0.020 |
Why?
|
Models, Biological | 3 | 2013 | 9464 | 0.020 |
Why?
|
Inhalation | 1 | 2012 | 143 | 0.020 |
Why?
|
Biomedical Engineering | 1 | 2012 | 284 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8504 | 0.020 |
Why?
|
Calibration | 1 | 2012 | 817 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3773 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 2012 | 720 | 0.020 |
Why?
|
Trans-Activators | 1 | 2018 | 2856 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6210 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2017 | 1921 | 0.020 |
Why?
|
Patient Compliance | 1 | 2016 | 2697 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18401 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26396 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15851 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14766 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30238 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 4968 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5754 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20741 | 0.010 |
Why?
|
Adolescent | 1 | 2023 | 89046 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 81659 | 0.010 |
Why?
|
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_